Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares shot up 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares traded hands during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The business has a 50-day moving average of C$0.07 and a 200-day moving average of C$0.06. The company has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Start Investing in Real Estate
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How is Compound Interest Calculated?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- EV Stocks and How to Profit from Them
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
